Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.

Headline

FDA approves desmopressin nasal spray for nocturnal polyuria

Comment

Desmopressin is already used in pediatrics for treating nocturnal enuresis in otherwise normal children, though failure of response is encountered occasionally, as the the etiology therein is multifactorial. With such a decision of FDA herein, questions remain; in polycystic kidney disease for ex, characterized by polyuria, would we use it?! I am not sure, also, if in other conditions where an overactive bladder is the cause, the benefits outweigh the risk.! I believe use of other modes, ex anticholinergics, has already been established and is safer! Dr Hana Fayyad, pediatrician

Posted date

12 MAR 2017

Posted time

9:43

Mandatory
Mandatory
Mandatory
Mandatory

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.